HomeCompareLMLLF vs MRK

LMLLF vs MRK: Dividend Comparison 2026

LMLLF yields 26315.79% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LMLLF wins by $802085897127229390848.00M in total portfolio value
10 years
LMLLF
LMLLF
● Live price
26315.79%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$802085897127229390848.00M
Annual income
$796,134,651,160,688,600,000,000,000.00
Full LMLLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LMLLF vs MRK

📍 LMLLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLMLLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LMLLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LMLLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LMLLF
Annual income on $10K today (after 15% tax)
$2,236,842.11/yr
After 10yr DRIP, annual income (after tax)
$676,714,453,486,585,300,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, LMLLF beats the other by $676,714,453,486,585,300,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LMLLF + MRK for your $10,000?

LMLLF: 50%MRK: 50%
100% MRK50/50100% LMLLF
Portfolio after 10yr
$401042948563614695424.00M
Annual income
$398,067,325,580,344,300,000,000,000.00/yr
Blended yield
99.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LMLLF
No analyst data
Altman Z
-103.8
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LMLLF buys
0
MRK buys
0
No recent congressional trades found for LMLLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLMLLFMRK
Forward yield26315.79%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$802085897127229390848.00M$56.8K
Annual income after 10y$796,134,651,160,688,600,000,000,000.00$9,798.13
Total dividends collected$801694023521105215488.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LMLLF vs MRK ($10,000, DRIP)

YearLMLLF PortfolioLMLLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,642,279$2,631,578.95$11,206$366.19+$2.63MLMLLF
2$652,674,496$649,847,257.10$12,650$502.35+$652.66MLMLLF
3$150,717,093,655$150,018,731,944.79$14,407$694.19+$150717.08MLMLLF
4$32,537,594,543,311$32,376,327,253,099.92$16,585$967.82+$32537594.53MLMLLF
5$6,567,124,460,012,792$6,532,309,233,851,450.00$19,342$1,363.89+$6567124459.99MLMLLF
6$1,239,202,870,261,231,900$1,232,176,047,089,018,000.00$22,913$1,947.19+$1239202870261.21MLMLLF
7$218,624,156,631,620,120,000$217,298,209,560,440,600,000.00$27,662$2,823.89+$218624156631620.09MLMLLF
8$36,062,384,982,353,154,000,000$35,828,457,134,757,322,000,000.00$34,159$4,173.35+$36062384982353152.00MLMLLF
9$5,561,912,118,262,444,000,000,000$5,523,325,366,331,326,000,000,000.00$43,337$6,308.80+$5561912118262444032.00MLMLLF
10$802,085,897,127,229,400,000,000,000$796,134,651,160,688,600,000,000,000.00$56,776$9,798.13+$802085897127229390848.00MLMLLF

LMLLF vs MRK: Complete Analysis 2026

LMLLFStock

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.

Full LMLLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LMLLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LMLLF vs SCHDLMLLF vs JEPILMLLF vs OLMLLF vs KOLMLLF vs MAINLMLLF vs JNJLMLLF vs ABBVLMLLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.